Pelvic Inflammatory Disease;Zdjelična Upalna Bolest

Medicus

Volumn 12, Issue 2, 2003, Pages 189-192

  Vrčić, Hrvoje ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Agents; Epidemiology; Pelvic inflammatory disease; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFOTETAN; CEFOXITIN; CEPHALOSPORIN; CHLORTETRACYCLINE; CLINDAMYCIN; CLOXACILLIN; GENTAMICIN; METRONIDAZOLE; OFLOXACIN; PROBENECID; TETRACYCLINE;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENDOMETRIOSIS; HUMAN; INFECTION PREVENTION; INFECTION RISK; MICROORGANISM; OVARY INFLAMMATION; PELVIC INFLAMMATORY DISEASE; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME; VAGINITIS;

EID: 1942469998     PISSN: 1330013X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. McCORMACK WM. Pelvic inflammatory disease. N Engl J Med 1994; 330: 115-9.
2. nd ed. New York: McGrow-Hill, 1990: 615-20.
3. WOLNER-HANSSEN P, ESCHENBACH DA, PAAVONEN J et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990; 263: 54-9.
4. PAAVONEN J, LEHTINEN M. Chlamydial pelvic inflammatory disease. Human Reprod Update 1996; 2: 519-29.
5. WESTROM L. Epidemiology of pelvic inflammatory disease. In: Ludwig H, Thomsen K, (eds.) Gynecology and Obstetrics. New York: Springer-Verlag, 1986: 659-61.
6. ARAL SO, MOSHER WD, CATES W Jr. Self reported pelvic inflammatory disease in the United States, 1988. JAMA 1991; 266: 2570-3.
7. STAMM WE, GUINAN ME, JOHNSON C. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infections with Chlamydia trachomatis. N Engl J Med 1984; 310: 545-9.
8. PAAVONEN J, TEISALA K, HEINONEN PK et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynecol 1987; 94: 454-60.
9. SOPER DE, BROCKWELL NJ, DALTON HP et al. Observations concerning microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994; 170: 1 008-17.
10. SWEET RL. Role of Bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995; 20(Suppl 2): 271-5.
11. PAAVONEN J, KIVIAT N, BRUNHAM RC et al. Prevalence and manifestation of endometritis among women with cervicitis. Am J Obstet Gynecol 1985; 152: 280-6.
12. SOPER DE. Diagnosis and laparoscopic grading of acute salpingitis. Am J Obstet Gynecol 1991; 164: 1370-6.
13. BEVAN DC, RIDGWAY LG, ROTHERMEL DC. An open-Label, Comparative Study of Intravenous and Oral Azithromycin Alone or with Metronidasole vs. Doxicycline + Cefoxitin + Met + Probenecid for the Treatment of PID. ICMAS. 2000: 05.33.
14. WALES NM, BARTON SE, BOAG FC. et al. An audit of the management of pelvic inflammatory disease. Int J STD AIDS 1997; 8: 409-11.
15. CDC. Pelvic inflammatory disease: Guidelines for prevention and management. MMWR 2002; 51(RR-6): 48-51.
16. WHO: Infections, pregnancies, and infertility: Perspectives on prevention. Fertil Steril 1987; 47: 964-8.
17. MAKINEN JL, SALMI TA, NIKKANEN VPJ et al. Encouraging rates of fertility after ectopic pregnancy. Int J Fertil 1989; 34: 46-51.